Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Guangdong Zhongsheng Ruichuang Pharmaceutical Co. Ltd. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, ...

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic ...

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Across our campus and throughout our nearly 400 years, Harvard innovation—in medicine, technology, education, and beyond—has ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...